CRISPR
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CEOSamarth Kulkarni
CEOSamarth Kulkarni
Employees407
Employees407
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2013
Founded2013
Employees407
Employees407
CRSP Key Statistics
Market cap3.96B
Market cap3.96B
Price-Earnings ratio-16.74
Price-Earnings ratio-16.74
Dividend yield—
Dividend yield—
Average volume2.12M
Average volume2.12M
High today$47.60
High today$47.60
Low today$46.02
Low today$46.02
Open price$47.21
Open price$47.21
Volume188.50K
Volume188.50K
52 Week high$91.10
52 Week high$91.10
52 Week low$43.42
52 Week low$43.42
Analyst ratings
50%
of 30 ratingsBuy
50%
Hold
40%
Sell
10%